Current:Home > BackBurger King parent company to buy out largest franchisee to modernize stores-DB Wealth Institute B2 Expert Reviews
Burger King parent company to buy out largest franchisee to modernize stores
View Date:2024-12-25 02:01:21
Burger King's parent company is about to "have it their way" at more locations.
Restaurant Brands International Inc. announced Tuesday that it would purchase the issued and outstanding shares of Burger King franchisee Carrols Restaurant Group Inc. for $9.55 per share at a value of approximately $1 billion.
Carrols is the largest Burger King franchisee in the country, operating 1,022 Burger King restaurants in 23 states and 60 Popeyes locations.
Restaurant Brands said that it will invest $500 million to renovate approximately 600 restaurants that were acquired in the transaction.
"We are going to rapidly remodel these restaurants over the next five years or so and put them back into the hands of motivated, local franchisees," Tom Curtis, president of Burger King U.S. and Canada, said in the statement announcing the deal.
Purchase part of modernization
The transaction is a part of Restaurant Brands' effort to modernize Burger King locations. The company originally announced the "Reclaim the Flame" plan in 2022 and said it would invest $400 million in restaurant improvements over two years.
"We need pretty much every Burger King all across the country to be modern, convenient and competitive with all of the other concepts out there that have new and modern buildings,” Restaurant Brands CEO Joshua Kobza said during a conference call with investors in August, according to the Associated Press.
In the announcement Restaurant Brands, which owns the Burger King, Tim Hortons, Popeyes and Firehouse Subs brands, said it would keep "a couple of hundred restaurants for strategic innovation, training, and operator development purposes."
The deal includes a 30-day "go shop" period for Carrol's to solicit other offers.
veryGood! (81)
Related
- 'Heretic' spoilers! Hugh Grant spills on his horror villain's fears and fate
- A sight not seen in decades: The kennels finally empty at this animal shelter
- Simone Biles and Jonathan Owens Have a Winning Christmas Despite Relationship Criticism
- Holiday travel is mostly nice, but with some naughty disruptions again on Southwest Airlines
- Ryan Reynolds Makes Dream Come True for 9-Year-Old Fan Battling Cancer
- Simone Biles and Jonathan Owens Have a Winning Christmas Despite Relationship Criticism
- Philadelphia Eagles nearly gift game to New York Giants, survive sloppy second half in win
- Amanda Bynes Shows Off Brief Black Hair Transformation Amid New Chapter
- Veterans face challenges starting small businesses but there are plenty of resources to help
- Raiders score huge win in Kansas City to keep Chiefs from clinching AFC West
Ranking
- Democrat Cleo Fields wins re-drawn Louisiana congressional district, flipping red seat blue
- Horoscopes Today, December 23, 2023
- Investment, tax tips for keeping, growing your money in 2024
- Liverpool star Mohamed Salah ‘shares pain’ of grieving families at Christmas amid Israel-Hamas war
- Dave Coulier Says He's OK If This Is the End Amid Stage 3 Non-Hodgkin’s Lymphoma Battle
- 'Aquaman 2' off to frigid start with $28M debut in Christmas box office
- Southwest Airlines cancels hundreds of flights, disrupting some holiday travelers
- 32 things we learned in NFL Week 16: Christmas gifts arrive early – for some teams
Recommendation
-
Tech consultant testifies that ‘bad joke’ led to deadly clash with Cash App founder Bob Lee
-
Towns reinforce dikes as heavy rains send rivers over their banks in Germany and the Netherlands
-
Atlanta woman's wallet lost 65 years ago returns to family who now have 'a piece of her back'
-
Taylor Swift Spends Christmas With Travis Kelce at NFL Game
-
New York eyes reviving congestion pricing toll before Trump takes office
-
Eagles end 3-game skid, keep NFC East title hopes alive with 33-25 win over Giants
-
A guesthouse blaze in Romania leaves 5 dead and others missing
-
Sickle cell patient's journey leads to landmark approval of gene-editing treatment